PETER R. MAHRER, M.D.; JOHN A. EVANS, M.D.; ISRAEL STEINBERG, M.D., F.A.C.P.
This content is PDF only. Please click on the PDF icon to access.
Scleroderma is a systemic disease involving the collagenous tissues. The skin, gastrointestinal tract, and the cardiovascular, musculoskeletal, genitourinary and pulmonary systems may be involved. Dysphagia is a common complaint with esophageal involvement. The purpose of this report is to evaluate the lung changes in the cases reported in the literature, to add our own experience in 16 patients and to examine the relationship of the pulmonary changes and dysphagia.
The first authenticated cases of pulmonary lesions with generalized scleroderma were described by Matsui1 in 1924. He reported six postmortem cases, two of which had fibrosis of the
MAHRER PR, EVANS JA, STEINBERG I. SCLERODERMA: RELATION OF PULMONARY CHANGES TO ESOPHAGEAL DISEASE1. Ann Intern Med. 1954;40:92–110. doi: 10.7326/0003-4819-40-1-92
Download citation file:
Published: Ann Intern Med. 1954;40(1):92-110.
Esophageal Disorders, Gastroenterology/Hepatology, Pulmonary/Critical Care, Rheumatology, Scleroderma.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use